Xeris Biopharma Holdings, Inc. XERS Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $111.04M+55.0% | $71.62M+6.2% | $67.45M-44.7% | $121.97M+81.3% | ||
| $204.18M+26.5% | $161.41M+10.4% | $146.25M+36.1% | $107.49M+195% | ||
| $68.67M+42.5% | $48.18M+24.0% | $38.84M+57.0% | $24.74M+36.5% | ||
| $9.55M+28.1% | $7.45M+29.0% | $5.78M-37.8% | $9.29M+102% | ||
| $240.31M+43.3% | $167.66M+7.3% | $156.26M-16.4% | $186.82M+31.0% | ||
| $4.95M-11.1% | $5.56M-6.8% | $5.97M+8.2% | $5.52M-16.8% | ||
| $22.11M-2.4% | $22.65M-2.4% | $23.2M+481% | $3.99M— | ||
| $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | $22.86M0.0% | ||
| $88.08M-11.0% | $98.92M-9.9% | $109.76M-9.0% | $120.61M-8.2% | ||
| $5.22M-3.5% | $5.41M+19.1% | $4.54M-4.0% | $4.73M+471% | ||
| $383.53M+18.7% | $323.06M+0.1% | $322.6M-6.4% | $344.52M+13.2% | ||
| $3.08M+34.3% | $2.29M-80.2% | $11.57M+151% | $4.61M-48.4% | ||
| $4.89M+349% | $1.09M-6.7% | $1.17M-56.1% | $2.66M+33.8% | ||
| $6.23M+2.5% | $6.08M+74.0% | $3.5M+121% | $1.58M— | ||
| $109.57M+9.1% | $100.44M+5.5% | $95.19M+29.3% | $73.62M-6.9% | ||
| $220.34M+1.5% | $217.01M+13.7% | $190.93M+2.1% | $187.08M+112% | ||
| $31.53M-5.2% | $33.26M-4.3% | $34.76M+270% | $9.4M— | ||
| $37.76M-4.0% | $39.34M+2.8% | $38.26M+248% | $10.98M— | ||
| $8.4M+327% | $1.97M-59.4% | $4.85M+15,539% | $31K-98.2% | ||
| $369.84M+4.9% | $352.68M+7.1% | $329.38M+10.0% | $299.34M+43.1% | ||
| $0— | $0— | $0— | $0— | ||
| $17K+13.3% | $15K+7.1% | $14K0.0% | $14K+7.7% | ||
| $685M+6.7% | $642.26M+5.2% | $610.25M+1.7% | $599.97M+8.0% | ||
| -$671.31M+0.1% | -$671.86M-8.9% | -$617.03M-11.2% | -$554.77M-20.6% | ||
| -$25K0.0% | -$25K0.0% | -$25K-8.7% | -$23K+25.8% | ||
| $13.69M+146% | -$29.62M-337% | -$6.78M-115% | $45.19M-52.6% | ||
| $383.53M+18.7% | $323.06M+0.1% | $322.6M-6.4% | $344.52M+13.2% | ||
| $5.22M-3.5% | $5.41M+19.1% | $4.54M-4.0% | $4.73M+471% | ||
| $22.11M-2.4% | $22.65M-2.4% | $23.2M+481% | $3.99M— | ||
| $88.08M-11.0% | $98.92M-9.9% | $109.76M-9.0% | $120.61M-8.2% | ||
| $22.11M-2.4% | $22.65M-2.4% | $23.2M+481% | $3.99M— | ||
| $5.22M-3.5% | $5.41M+19.1% | $4.54M-4.0% | $4.73M+471% | ||
| $22.11M-2.4% | $22.65M-2.4% | $23.2M+481% | $3.99M— | ||
| $5.22M-3.5% | $5.41M+19.1% | $4.54M-4.0% | $4.73M+471% | ||
| $33.16M+19.6% | $27.72M+17.9% | $23.51M-36.1% | $36.79M-25.1% | ||
| $43.25M+48.7% | $29.08M+31.3% | $22.15M+31.7% | $16.82M+11.8% | ||
| $33.16M+19.6% | $27.72M+17.9% | $23.51M-36.1% | $36.79M-25.1% | ||
| $18.97M-0.6% | $19.08M+34.4% | $14.2M+27.1% | $11.17M+179% | ||
| $4.89M+349% | $1.09M-6.7% | $1.17M-56.1% | $2.66M+33.8% | ||
| $258.1M-4.9% | $271.45M+18.4% | $229.19M+15.7% | $198.06M+125% | ||
| $17K+13.3% | $15K+7.1% | $14K0.0% | $14K+7.7% | ||
| $0— | $0— | $0— | $0— | ||
| $9.55M+28.1% | $7.45M+29.0% | $5.78M-37.8% | $9.29M+102% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Xeris Biopharma Holdings, Inc.'s total assets?
- Xeris Biopharma Holdings, Inc. (XERS) holds $392.0M in total assets, up 24.3% year over year.
- How much debt does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. carries $258.6M in total debt against $13.0M of shareholders' equity, a debt-to-equity ratio of 19.87.
- How much cash does Xeris Biopharma Holdings, Inc. have?
- Xeris Biopharma Holdings, Inc. holds $111.8M in cash and equivalents.
- Can Xeris Biopharma Holdings, Inc. cover its short-term obligations?
- Its current ratio is 2.12 — current assets exceed current liabilities.
- Where does Xeris Biopharma Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Xeris Biopharma Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
